Market Cap | ₹31Cr |
ROE | -15.11% |
P/E Ratio(TTM) | -33.39 |
EPS(TTM) | -1.27 |
P/B Ratio | 5.14 |
Dividend Yield | 0.00% |
Industry P/E | 38.99 |
Book Value | 8.26 |
Debt to Equity | 0.15 |
Face Value | 10 |
Parent Organisation | Gujarat Terce Laboratories Limited |
Managing Director | Mr. Aalap Prajapati |
BSE Symbol | 524314 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 60.60 | ||
Gland Pharma | NA (0.00%) | 43.02 | ||
Ajanta Pharma | NA (0.00%) | 32.53 | ||
Eris Lifesciences | NA (0.00%) | 55.50 |